Interventional trials to decrease the incidence of non-AIDS-defining events among HIV-infected persons with virological suppression should consider targeting the pathways represented by these soluble markers. Clinical Trials Registration. NCT00001137.
No takes yet. Share an insight, caveat, or question.
Tenorio et al. (2014) studied this question.